Journal
BIOMARKER RESEARCH
Volume 10, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s40364-022-00366-4
Keywords
RNA-binding protein; HnRNP C; Cancers; Molecular interactions
Categories
Funding
- Hunan Natural Science Foundation [2020JJ4530]
- Research Initiation Funding of University of South China [2018XQD09]
- Science and Technology Foundation of Hengyang [2020jh042697, 2020-67-9]
- University Students Study and Innovation Pilot Project [2020-191-2792]
Ask authors/readers for more resources
This paper reviews the regulation and dysregulation of HnRNP C in cancers. HnRNP C interacts with various biological molecules and plays a role in regulating the stability and translation of cancer genes. It is considered as a potential biomarker and valuable for prognosis evaluation.
Heterogeneous nuclear ribonucleoproteins C (HnRNP C) is part of the hnRNP family of RNA-binding proteins. The relationship between hnRNP C and cancers has been extensively studied, and dysregulation of hnRNP C has been found in many cancers. According to existing public data, hnRNP C could promote the maturation of new heterogeneous nuclear RNAs (hnRNA s, also referred to as pre-mRNAs) into mRNAs and could stabilize mRNAs, controlling their translation. This paper reviews the regulation and dysregulation of hnRNP C in cancers. It interacts with some cancer genes and other biological molecules, such as microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and double-stranded RNAs (dsRNAs). Even directly binds to them. The effects of hnRNP C on biological processes such as alternative cleavage and polyadenylation (APA) and N6-methyladenosine (m6A) modification differ among cancers. Its main function is regulating stability and level of translation of cancer genes, and the hnRNP C is regarded as a candidate biomarker and might be valuable for prognosis evaluation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available